1. Home
  2. GCGR vs THW Comparison

GCGR vs THW Comparison

Compare GCGR & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GCGR

General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

N/A

Current Price

$10.00

Market Cap

461.9M

Sector

N/A

ML Signal

N/A

Logo abrdn World Healthcare Fund Shares of Beneficial Interest

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

SELL

Current Price

$12.92

Market Cap

484.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
GCGR
THW
Founded
2026
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
461.9M
484.8M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
GCGR
THW
Price
$10.00
$12.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 110.2K
101.0K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.95
$11.18
52 Week High
$10.20
$14.50

Technical Indicators

Market Signals
Indicator
GCGR
THW
Relative Strength Index (RSI) 42.60 50.50
Support Level $9.96 $12.72
Resistance Level $10.12 $13.76
Average True Range (ATR) 0.03 0.30
MACD -0.00 0.05
Stochastic Oscillator 33.33 52.34

Price Performance

Historical Comparison
GCGR
THW

About GCGR General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

General Catalyst Global Resilience Merger Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

Share on Social Networks: